Yes, several autoimmune diseases directly affect tendons, and tendon involvement is a hallmark feature of some of the most common ones. Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, lupus, scleroderma, and polymyalgia rheumatica can all damage tendons or the tissue surrounding them, though each does so in a distinct way.
Rheumatoid Arthritis and Tendon Sheath Inflammation
Rheumatoid arthritis (RA) is one of the most recognized autoimmune causes of tendon problems. The disease targets the synovial sheath, a thin membrane that wraps around tendons in the hands, wrists, and feet. When this sheath becomes inflamed, the condition is called tenosynovitis. It causes pain, swelling, and the prolonged morning stiffness that many RA patients describe as their most disruptive symptom.
Tenosynovitis isn’t just a side effect of RA. It’s now considered a core feature of the disease. MRI studies have shown that tendon sheath inflammation in the wrists and hands is present even in early RA, before joint damage becomes visible. It can appear on the back of the hand and along the tendons that run through the wrist and into the fingers. Over time, persistent inflammation can weaken tendons enough to cause rupture, particularly the tendons that straighten the fingers.
Psoriatic Arthritis and Enthesitis
Psoriatic arthritis (PsA) attacks tendons at a different point: where they attach to bone. These attachment sites are called entheses, and inflammation at these sites, called enthesitis, is a hallmark of PsA and related conditions in the spondyloarthritis family. A large meta-analysis of over 84,000 PsA patients found that about 42% experience clinical enthesitis during the course of their disease.
The most commonly affected sites include the Achilles tendon at the back of the heel, the plantar fascia on the sole of the foot, and the spots where tendons attach around the knee and elbow. Unlike RA, which inflames the sheath around the middle of a tendon, PsA concentrates its attack at the bone-tendon junction. This distinction matters because it produces a different kind of pain, often felt as a deep ache right at the bone, and it responds to different treatments.
Ankylosing Spondylitis and Heel Pain
Ankylosing spondylitis (AS) is best known for causing spinal stiffness and fusion, but tendon inflammation is a significant part of the disease. Roughly 30 to 40% of patients with axial spondyloarthritis develop peripheral enthesitis at some point, and the heel is the most frequently affected location. The Achilles tendon insertion and the plantar fascia insertion both sit at the back and bottom of the heel, making heel pain one of the earliest clues that someone’s back pain may have an autoimmune origin rather than a mechanical one.
In a registry study of 749 AS patients, about 6% had active Achilles enthesitis on physical exam at a single visit, and those patients went on to have worse functional outcomes over two years of follow-up. For someone with persistent heel pain that doesn’t respond to rest, orthotics, or physical therapy, especially if they also have chronic low back pain that improves with movement, enthesitis from spondyloarthritis is worth considering.
Lupus and Tendon Rupture Risk
Systemic lupus erythematosus (SLE) affects tendons in a less obvious but potentially more dangerous way. Rather than causing visible swelling, lupus creates chronic, low-grade inflammation that weakens the internal structure of tendons over time. Even during periods of mild disease activity, subclinical inflammation persists. Tissue samples from ruptured tendons in lupus patients show inflammatory changes with immune cells clustered around small blood vessels.
This weakening can lead to spontaneous tendon rupture, meaning the tendon snaps during a routine activity that wouldn’t normally cause injury. The patellar tendon (connecting the kneecap to the shinbone) and the Achilles tendon are the most reported sites. In one study tracking 180 lupus patients over 10 years, four experienced patellar tendon rupture.
Corticosteroids, a mainstay of lupus treatment, compound the problem. They reduce the replication of fibroblasts (the cells that build and maintain tendon tissue), decrease collagen production, and increase the activity of enzymes that break collagen down. The combination of autoimmune inflammation plus long-term steroid use creates a double hit to tendon integrity.
Scleroderma and Tendon Friction Rubs
Scleroderma, or systemic sclerosis, produces a unique tendon finding that doesn’t occur in other autoimmune diseases. As the disease causes fibrosis (thickening and scarring) of tissues around tendons, the tendons lose their ability to glide smoothly. When a doctor moves the affected joint, they can feel a coarse, leathery crepitus called a tendon friction rub. It’s been described as a grating sensation palpable through the skin during movement.
This finding is more than a curiosity. It’s one of the most important prognostic markers in scleroderma. Patients with tendon friction rubs have a significantly increased risk of developing kidney crisis (2.7 times higher), cardiac involvement (3.3 times higher), and gastrointestinal complications (5.1 times higher) compared to scleroderma patients without them. Five-year survival drops from 81% to 68% when friction rubs are present. Their detection during a physical exam can prompt earlier, more aggressive monitoring of internal organs.
Polymyalgia Rheumatica and Shoulder Tendons
Polymyalgia rheumatica (PMR) causes severe stiffness and aching in the shoulders and hips, typically in people over 50. The pain often feels muscular, but imaging reveals that much of it originates from inflamed bursae and tendon sheaths. Ultrasound and MRI in PMR patients commonly identify inflammation of the biceps tendon sheath at the shoulder, along with bursitis beneath the deltoid muscle. Biceps tenosynovitis in both shoulders is actually part of the classification criteria used to diagnose the condition.
How Autoimmune Tendon Pain Differs From Overuse
One of the most practical things to understand is how autoimmune tendon inflammation feels compared to the kind you get from overdoing it at the gym or from repetitive work. The differences are consistent enough to help you recognize when something beyond simple overuse might be happening.
Mechanical tendon pain from overuse gets worse with activity and improves with rest. Autoimmune tendon inflammation behaves in the opposite way: it’s worst after periods of inactivity and improves with movement. Morning stiffness is the clearest dividing line. People with autoimmune tendon involvement typically wake up stiff and need 30 minutes to several hours before the affected area loosens up. With mechanical tendonitis, morning stiffness is usually absent or very brief.
Other clues pointing toward an autoimmune cause include tendon pain in multiple locations simultaneously, pain that doesn’t match a clear injury or overuse pattern, swelling that seems out of proportion to activity level, and tendon symptoms accompanied by fatigue, skin changes, or joint swelling elsewhere in the body.
How Tendon Involvement Is Detected
Physical examination catches obvious tendon swelling and tenderness, but subclinical inflammation often requires imaging. Ultrasound and MRI each have strengths for evaluating autoimmune tendon disease. A study comparing the two in patients with psoriatic arthritis and rheumatoid arthritis found that MRI was more sensitive for detecting active inflammation, picking up abnormalities in 35% of cases where ultrasound appeared normal. Ultrasound, on the other hand, was better at identifying structural damage like erosions and tears. In practice, ultrasound is often used first because it’s quick, inexpensive, and available in many rheumatology offices, while MRI is reserved for cases where deeper tissue detail is needed.
Treatment for Autoimmune Tendon Inflammation
Treating autoimmune tendon problems means treating the underlying disease. Standard anti-inflammatory medications and disease-modifying drugs form the foundation, but for enthesitis specifically, newer biologic therapies have shown meaningful differences in effectiveness.
A network meta-analysis of treatments for enthesitis in psoriatic arthritis compared several drug classes head-to-head. At 24 weeks, drugs that block a specific immune signaling pathway inside cells (JAK inhibitors) showed the highest rates of complete enthesitis resolution, followed by drugs targeting a protein called IL-17 that drives inflammation at tendon attachment sites. Both classes outperformed the older standard biologic approach of blocking a protein called TNF-alpha. The differences were significant enough that treatment guidelines now increasingly recommend these newer options when enthesitis is a dominant symptom.
For tendon problems driven by lupus or scleroderma, the approach focuses on controlling the broader disease activity while being mindful that some treatments, particularly corticosteroids, can themselves weaken tendons. Physical therapy plays a supporting role across all these conditions by maintaining tendon strength and joint mobility while the immune-targeted medications work to reduce inflammation.